Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients

BACKGROUND: Interferon-based therapy (IBT) has been the standard of care for hepatitis C virus (HCV) infection. However, conflicting results exist regarding the effects of IBT on risk of developing hepatocellular carcinoma (HCC) and cirrhosis-associated complications, and most included highly select...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Hsu, Ching-Sheng, Huang, Chun-Jen, Kao, Jia-Horng, Lin, Hans Hsienhong, Chao, You-Chen, Fan, Yen-Chun, Tsai, Pei-Shan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720923/
https://ncbi.nlm.nih.gov/pubmed/23894660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0070458
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak